ARTEMISMED vs KIMS: Stock Comparison

Artemis Medicare Services Limited vs Krishna Institute of Medical Sciences Limited

Live data: 16 July 2026, 12:32 PM IST • Source: NSE and company filings

Krishna Institute of Medical Sciences Limited is the larger company by market capitalisation. Artemis Medicare Services Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Krishna Institute of Medical Sciences Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Artemis Medicare Services Limited and Krishna Institute of Medical Sciences Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ARTEMISMED is more favourable on 9 of 13 scored metrics and KIMS on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
KIMS is the larger company
₹32,151 Cr vs ₹4,387 Cr
P/E Ratio
ARTEMISMED has a lower P/E
42.14x vs 133.83x
P/B Ratio
ARTEMISMED has a lower P/B
4.67x vs 14.37x
EPS
KIMS has higher earnings per share
₹6.04 vs ₹2.29
Dividend Yield
ARTEMISMED has a higher dividend yield
0.17% vs 0%
Revenue Growth (TTM YoY)
KIMS has faster revenue growth
34.8% vs 14.1%
EPS Growth (TTM YoY)
ARTEMISMED has faster EPS growth
28.7% vs -58.3%
Qtr Sales Growth
KIMS has stronger quarterly sales growth
34.8% vs 16.4%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricARTEMISMEDKIMS
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricARTEMISMEDKIMS
Live Price₹277.5₹802
Day Change0.47%-0.74%
Volume62,6371.1 L
52-Week High₹297.5₹858
52-Week Low₹203.35₹575.8
Distance from 52W High-6.72%-6.53%

Valuation

MetricARTEMISMEDKIMS
Market Cap₹4,387 Cr₹32,151 Cr
P/E Ratio42.14x133.83x
P/B Ratio4.67x14.37x
EPS₹2.29₹6.04
Book Value₹59.16₹56.17
Dividend Yield0.17%0%

Growth

MetricARTEMISMEDKIMS
Revenue Growth (TTM YoY)14.1%34.8%
EPS Growth (TTM YoY)28.7%-58.3%
Qtr Sales Growth16.4%34.8%
Qtr Profit Growth30.4%-50.7%

Profitability & Leverage

MetricARTEMISMEDKIMS
ROE12%11.3%
ROCE14.6%9.29%
Net Margin9.58%6.18%
Operating Margin17.4%20.5%
Debt to Equity0x0.02x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricARTEMISMEDKIMS
Promoter Holding58.39%34.11%
FII Holding12.19% 0.28 pp14.57% 0.24 pp
DII Holding2.89% 0.02 pp32.5% 0.21 pp
Public Holding20.37% 0.29 pp18.82% 0.03 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Artemis Medicare Services Limited and Krishna Institute of Medical Sciences Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.